Melanie Healey, 52, remains group president-North America, but
will now report to Mr. Lafley as well as Vice Chairman-Global
Operations Werner Geissler, 60, a P&G vice chair. In a
statement, P&G said Ms. Healey reporting directly to Mr. Lafley
"reflects the size and impact of the North America market to
P&G's business," and that Mr. Geissler will now have
"particular focus on Western Europe and developing markets."
P&G's other vice chairman, Dimitri Panayatopoulos, 61, to
whom the other four group presidents reported, will retain the vice
chairman title, but as of the new fiscal year on July 1 will become
advisor to Mr. Lafley.
P&G will report its financial results for the four new
business-unit groupings as segments starting with the new fiscal
year, so results for all four executives will be easier to
distinguish. Though P&G doesn't report results quarterly for
Ms. Healey's North America unit, which doesn't have an external
profit-and-loss statement, it does report sales results for the
business annually.
All five have their work cut out for them. The only P&G
business unit to gain share over the past three quarters, according
to the company's quarterly reports, has been the global grooming
business – and that's one for which P&G just shifted
global advertising duties on the Gillette shaving brand from
BBDO to Grey. P&G's U.S. sales fell 5%
during the first three years of Mr. McDonald's watch as CEO, and
only recently turned in the first positive share month in more than
two years, according to Nielsen data from Sanford C. Bernstein.
P&G also reported another group president, Jorge Mesquita,
is leaving the company to pursue outside interests. He couldn't
immediately be reached for comment.
Charles Pierce, 56, now group president-global oral care, will
take on Mr. Mesquita's duties overseeing new business creation,
which Mr. Mesquita was assigned to lead only last year. Mr. Pierce
will also report both to Mr. Lafley in his new role and to Mr.
Taylor in his old one.
Another P&G group president, Steven Bishop, 49, will
continue to oversee feminine care but now will report to Mr. Riant
rather than Mr. Panayatopoulos.
The changes collectively "will strengthen our focus on
go-to-market excellence in our core developed and developing
markets," Mr. Lafley said in a statement, and "help us operate
better and faster as one unified team to win."